Edson J R, Swinehart C D
Am J Clin Pathol. 1976 Jun;65(6):957-63. doi: 10.1093/ajcp/65.6.957.
Three anti-Factor-VIII antibodies from hemophiliacs were reacted with samples of batches of Maws commerical bovine and porcine Factor VIII concentrates manufactured over a 12-year period. The apparent antibody concentrations varied widely with the different batches of concentrates. The variations are probably due to intrinsic differences in the antigenic nature of the Factor VIII in the different preparations. With the older porcine concentrates, the low apparent concentrations may be in part due to the reaction of antibody with inactive Factor VIII. When animal Factor VIII concentrates are used in treating hemophiliac patients who have anti-Factor-VIII antibodies, the least reactive batch should be chosen. Random batches of animal concentrates are not suited as a standard for measuring anti-Factor-VIII antibody concentration.
将来自血友病患者的三种抗凝血因子VIII抗体与在12年期间生产的多批Maws商业牛和猪凝血因子VIII浓缩物样本进行反应。不同批次浓缩物的表观抗体浓度差异很大。这些差异可能是由于不同制剂中凝血因子VIII抗原性质的内在差异所致。对于较老的猪浓缩物,低表观浓度可能部分是由于抗体与无活性凝血因子VIII的反应。当使用动物凝血因子VIII浓缩物治疗患有抗凝血因子VIII抗体的血友病患者时,应选择反应性最低的批次。随机批次的动物浓缩物不适合作为测量抗凝血因子VIII抗体浓度的标准。